Results
Rossari Biotech Q1 FY27 Revenue Up 28% YoY
Rossari Biotech reported Q1 FY27 consolidated revenue growth of 28.2% YoY to ₹697.2 crore, driven by broad-based growth across HPPC, TSC, and AHN segments.
EBITDA grew 18.7% YoY to ₹80.6 crore, though
